Correlation Between Fidelity Advisor and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Fidelity Advisor and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Advisor and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fidelity Advisor Diversified and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Fidelity Advisor and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Advisor with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Advisor and Franklin Biotechnology.

Diversification Opportunities for Fidelity Advisor and Franklin Biotechnology

0.88

Correlation Coefficient

Fidelity Advisor  Franklin Biotechnology

Very poor diversification

The 3 months correlation between Fidelity and Franklin is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Advisor Diversified and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Fidelity Advisor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Advisor Diversified are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Fidelity Advisor i.e., Fidelity Advisor and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Fidelity Advisor and Franklin Biotechnology

Assuming the 90 days horizon Fidelity Advisor Diversified is expected to generate 0.64 times more return on investment than Franklin Biotechnology. However, Fidelity Advisor Diversified is 1.57 times less risky than Franklin Biotechnology. It trades about -0.17 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about -0.14 per unit of risk. If you would invest  2,852  in Fidelity Advisor Diversified on October 6, 2024 and sell it today you would lose (313.00) from holding Fidelity Advisor Diversified or give up 10.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Fidelity Advisor Diversified  vs.  Franklin Biotechnology Discove

Fidelity Advisor Div

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fidelity Advisor Diversified has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Fidelity Advisor and Franklin Biotechnology

The main advantage of trading using opposite Fidelity Advisor and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Advisor position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Fidelity Advisor Diversified and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.